Concepedia

Toshihiro Hamajima

TH

Statistics

Publications

8

Citations

324

H-Index

8

Active since

2002

Affiliations

Tokyo University of Science(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (Japan)

Astellas Pharma (Japan)

Research Triangle Park Foundation

Toshihiro Hamajima is an author at Tokyo University of Science specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2002–2018

8

Publications

8

Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase

Nicholas D. Adams, Jerry L. Adams, Joelle L. Burgess et al. · Journal of Medicinal Chemistry · 2010 · 111 citations · Full text

, , +14

Yb(OTf)3-catalyzed cyclization of an N-silylenamine with 2-methylene-1,3-cyclohexanedione to afford a 7,8-dihydroquinolin-5(6H)-one derivative and its application to the one-pot conversion to a 2,3,5-trisubstituted quinoline derivative

Norio Sakai, Daisuke Aoki, Toshihiro Hamajima et al. · Tetrahedron Letters · 2006 · 47 citations

, , +15

4-Hydroxypyridazin-3(2<i>H</i>)-one Derivatives as Novel<scp>d</scp>-Amino Acid Oxidase Inhibitors

Takeshi Hondo, Masaichi Warizaya, Tatsuya Niimi et al. · Journal of Medicinal Chemistry · 2013 · 45 citations · Full text

, , +17

Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors

Jun Tang, Toshihiro Hamajima, Masato Nakano et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 35 citations · Full text

, , +14

Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase

Samarjit Patnaik, Kirk L. Stevens, Roseanne Gerding et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 26 citations · Full text

, , +16

1–5 of 8